{"id":"https://openalex.org/W3135089232","doi":"https://doi.org/10.1089/vim.2020.0321","title":"Antibody (IgA, IgG, and IgG Subtype) Responses to SARS-CoV-2 in Severe and Nonsevere COVID-19 Patients","display_name":"Antibody (IgA, IgG, and IgG Subtype) Responses to SARS-CoV-2 in Severe and Nonsevere COVID-19 Patients","publication_year":2021,"publication_date":"2021-03-03","ids":{"openalex":"https://openalex.org/W3135089232","doi":"https://doi.org/10.1089/vim.2020.0321","mag":"3135089232","pmid":"https://pubmed.ncbi.nlm.nih.gov/33656935"},"language":"en","primary_location":{"id":"doi:10.1089/vim.2020.0321","doi":"https://doi.org/10.1089/vim.2020.0321","is_oa":false,"landing_page_url":"https://doi.org/10.1089/vim.2020.0321","pdf_url":null,"source":{"id":"https://openalex.org/S203476268","display_name":"Viral Immunology","issn_l":"0882-8245","issn":["0882-8245","1557-8976"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-3","vabb-shw"],"host_organization":"https://openalex.org/P4310320443","host_organization_name":"Mary Ann Liebert, Inc.","host_organization_lineage":["https://openalex.org/P4310320443","https://openalex.org/P4310320017"],"host_organization_lineage_names":["Mary Ann Liebert, Inc.","SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Viral Immunology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5035952908","display_name":"Harshad P. Patil","orcid":"https://orcid.org/0000-0002-2345-9266","observed_orcids":["https://orcid.org/0000-0002-2345-9266"]},"institutions":[{"id":"https://openalex.org/I887998513","display_name":"Bharati Vidyapeeth (Deemed to be University)","ror":"https://ror.org/0052mmx10","country_code":"IN","type":"education","lineage":["https://openalex.org/I887998513"]}],"countries":["IN"],"is_corresponding":false,"raw_author_name":"Harshad P. Patil","raw_affiliation_strings":["Department of Communicable Diseases, Interactive Research School for Health Affairs (IRSHA), Bharati Vidyapeeth (Deemed to be University), Pune, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Communicable Diseases, Interactive Research School for Health Affairs (IRSHA), Bharati Vidyapeeth (Deemed to be University), Pune, India","institution_ids":["https://openalex.org/I887998513"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5003133676","display_name":"Prajakta S. Rane","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I887998513","display_name":"Bharati Vidyapeeth (Deemed to be University)","ror":"https://ror.org/0052mmx10","country_code":"IN","type":"education","lineage":["https://openalex.org/I887998513"]}],"countries":["IN"],"is_corresponding":false,"raw_author_name":"Prajakta S. Rane","raw_affiliation_strings":["Department of Communicable Diseases, Interactive Research School for Health Affairs (IRSHA), Bharati Vidyapeeth (Deemed to be University), Pune, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Communicable Diseases, Interactive Research School for Health Affairs (IRSHA), Bharati Vidyapeeth (Deemed to be University), Pune, India","institution_ids":["https://openalex.org/I887998513"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040958094","display_name":"Shubham Shrivastava","orcid":"https://orcid.org/0000-0002-5980-8536","observed_orcids":["https://orcid.org/0000-0002-5980-8536"]},"institutions":[{"id":"https://openalex.org/I887998513","display_name":"Bharati Vidyapeeth (Deemed to be University)","ror":"https://ror.org/0052mmx10","country_code":"IN","type":"education","lineage":["https://openalex.org/I887998513"]}],"countries":["IN"],"is_corresponding":false,"raw_author_name":"Shubham Shrivastava","raw_affiliation_strings":["Department of Communicable Diseases, Interactive Research School for Health Affairs (IRSHA), Bharati Vidyapeeth (Deemed to be University), Pune, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Communicable Diseases, Interactive Research School for Health Affairs (IRSHA), Bharati Vidyapeeth (Deemed to be University), Pune, India","institution_ids":["https://openalex.org/I887998513"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022822516","display_name":"Sonali Hemant Palkar","orcid":"https://orcid.org/0000-0002-8799-5156","observed_orcids":["https://orcid.org/0000-0002-8799-5156"]},"institutions":[{"id":"https://openalex.org/I887998513","display_name":"Bharati Vidyapeeth (Deemed to be University)","ror":"https://ror.org/0052mmx10","country_code":"IN","type":"education","lineage":["https://openalex.org/I887998513"]}],"countries":["IN"],"is_corresponding":false,"raw_author_name":"Sonali Palkar","raw_affiliation_strings":["Department of Pediatrics, Bharati Vidyapeeth (Deemed to be University) Medical College, Pune, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pediatrics, Bharati Vidyapeeth (Deemed to be University) Medical College, Pune, India","institution_ids":["https://openalex.org/I887998513"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5042324494","display_name":"Sanjay Kewalchand Lalwani","orcid":"https://orcid.org/0000-0003-4446-2357","observed_orcids":["https://orcid.org/0000-0003-4446-2357"]},"institutions":[{"id":"https://openalex.org/I887998513","display_name":"Bharati Vidyapeeth (Deemed to be University)","ror":"https://ror.org/0052mmx10","country_code":"IN","type":"education","lineage":["https://openalex.org/I887998513"]}],"countries":["IN"],"is_corresponding":false,"raw_author_name":"Sanjay Lalwani","raw_affiliation_strings":["Department of Pediatrics, Bharati Vidyapeeth (Deemed to be University) Medical College, Pune, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pediatrics, Bharati Vidyapeeth (Deemed to be University) Medical College, Pune, India","institution_ids":["https://openalex.org/I887998513"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5105987796","display_name":"Akhilesh Chandra Mishra","orcid":"https://orcid.org/0000-0003-1836-1990","observed_orcids":["https://orcid.org/0000-0003-1836-1990"]},"institutions":[{"id":"https://openalex.org/I887998513","display_name":"Bharati Vidyapeeth (Deemed to be University)","ror":"https://ror.org/0052mmx10","country_code":"IN","type":"education","lineage":["https://openalex.org/I887998513"]}],"countries":["IN"],"is_corresponding":false,"raw_author_name":"Akhilesh C. Mishra","raw_affiliation_strings":["Department of Communicable Diseases, Interactive Research School for Health Affairs (IRSHA), Bharati Vidyapeeth (Deemed to be University), Pune, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Communicable Diseases, Interactive Research School for Health Affairs (IRSHA), Bharati Vidyapeeth (Deemed to be University), Pune, India","institution_ids":["https://openalex.org/I887998513"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5002369853","display_name":"Vidya Avinash Arankalle","orcid":"https://orcid.org/0000-0002-9940-3437","observed_orcids":["https://orcid.org/0000-0002-9940-3437"]},"institutions":[{"id":"https://openalex.org/I887998513","display_name":"Bharati Vidyapeeth (Deemed to be University)","ror":"https://ror.org/0052mmx10","country_code":"IN","type":"education","lineage":["https://openalex.org/I887998513"]}],"countries":["IN"],"is_corresponding":false,"raw_author_name":"Vidya A. Arankalle","raw_affiliation_strings":["Department of Communicable Diseases, Interactive Research School for Health Affairs (IRSHA), Bharati Vidyapeeth (Deemed to be University), Pune, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Communicable Diseases, Interactive Research School for Health Affairs (IRSHA), Bharati Vidyapeeth (Deemed to be University), Pune, India","institution_ids":["https://openalex.org/I887998513"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I887998513"],"apc_list":null,"apc_paid":null,"fwci":2.8303,"has_fulltext":false,"cited_by_count":36,"citation_normalized_percentile":{"value":0.92716737,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":92,"max":99},"biblio":{"volume":"34","issue":"3","first_page":"201","last_page":"209"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10118","display_name":"SARS-CoV-2 and COVID-19 Research","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10118","display_name":"SARS-CoV-2 and COVID-19 Research","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10041","display_name":"COVID-19 Clinical Research Studies","score":0.0010000000474974513,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11754","display_name":"SARS-CoV-2 detection and testing","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/sars-cov-2","display_name":"SARS-CoV-2","score":0.9860000014305115},{"id":"https://openalex.org/keywords/covid-19","display_name":"COVID-19 pandemic","score":0.9890000224113464},{"id":"https://openalex.org/keywords/iga","display_name":"IgA","score":0.7829999923706055},{"id":"https://openalex.org/keywords/igg","display_name":"IgG","score":0.7639999985694885},{"id":"https://openalex.org/keywords/igg1","display_name":"IgG1","score":0.8640000224113464},{"id":"https://openalex.org/keywords/antibody-titers","display_name":"antibody titers","score":0.6949999928474426},{"id":"https://openalex.org/keywords/neutralizing-antibodies","display_name":"neutralizing antibodies","score":0.9769999980926514},{"id":"https://openalex.org/keywords/severe-covid-19","display_name":"severe COVID-19","score":0.7919999957084656},{"id":"https://openalex.org/keywords/disease-severity","display_name":"disease severity","score":0.781000018119812},{"id":"https://openalex.org/keywords/antibody-kinetics","display_name":"antibody kinetics","score":0.49000000953674316},{"id":"https://openalex.org/keywords/vaccine-induced-immunity","display_name":"vaccine-induced immunity","score":0.5519999861717224},{"id":"https://openalex.org/keywords/plaque-reduction-neutralization-test","display_name":"plaque reduction neutralization test","score":0.781000018119812}],"concepts":[{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.7680857181549072},{"id":"https://openalex.org/C32611913","wikidata":"https://www.wikidata.org/wiki/Q2166189","display_name":"Titer","level":3,"score":0.7432359457015991},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.7072339057922363},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7002980709075928},{"id":"https://openalex.org/C14086860","wikidata":"https://www.wikidata.org/wiki/Q337120","display_name":"Neutralization","level":3,"score":0.5262576341629028},{"id":"https://openalex.org/C2780898057","wikidata":"https://www.wikidata.org/wiki/Q79448","display_name":"Immunoglobulin G","level":3,"score":0.5099490880966187},{"id":"https://openalex.org/C22889606","wikidata":"https://www.wikidata.org/wiki/Q2166189","display_name":"Antibody titer","level":4,"score":0.4884547293186188},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.46804141998291016},{"id":"https://openalex.org/C3008058167","wikidata":"https://www.wikidata.org/wiki/Q84263196","display_name":"Coronavirus disease 2019 (COVID-19)","level":4,"score":0.46402958035469055},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.46348315477371216},{"id":"https://openalex.org/C2779102806","wikidata":"https://www.wikidata.org/wiki/Q79453","display_name":"Immunoglobulin A","level":4,"score":0.44421204924583435},{"id":"https://openalex.org/C3007834351","wikidata":"https://www.wikidata.org/wiki/Q82069695","display_name":"Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)","level":5,"score":0.43199998140335083},{"id":"https://openalex.org/C2779261636","wikidata":"https://www.wikidata.org/wiki/Q7003054","display_name":"Neutralizing antibody","level":3,"score":0.42982199788093567},{"id":"https://openalex.org/C159047783","wikidata":"https://www.wikidata.org/wiki/Q7215","display_name":"Virology","level":1,"score":0.42546209692955017},{"id":"https://openalex.org/C524204448","wikidata":"https://www.wikidata.org/wiki/Q788926","display_name":"Infectious disease (medical specialty)","level":3,"score":0.18650579452514648},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.14635607600212097}],"mesh":[{"descriptor_ui":"D000086382","descriptor_name":"COVID-19","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D000086402","descriptor_name":"SARS-CoV-2","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D000293","descriptor_name":"Adolescent","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000914","descriptor_name":"Antibodies, Viral","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":true},{"descriptor_ui":"D004797","descriptor_name":"Enzyme-Linked Immunosorbent Assay","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007070","descriptor_name":"Immunoglobulin A","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":true},{"descriptor_ui":"D007074","descriptor_name":"Immunoglobulin G","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":true},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009500","descriptor_name":"Neutralization Tests","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D055815","descriptor_name":"Young Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D057134","descriptor_name":"Antibodies, Neutralizing","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1089/vim.2020.0321","doi":"https://doi.org/10.1089/vim.2020.0321","is_oa":false,"landing_page_url":"https://doi.org/10.1089/vim.2020.0321","pdf_url":null,"source":{"id":"https://openalex.org/S203476268","display_name":"Viral Immunology","issn_l":"0882-8245","issn":["0882-8245","1557-8976"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-3","vabb-shw"],"host_organization":"https://openalex.org/P4310320443","host_organization_name":"Mary Ann Liebert, Inc.","host_organization_lineage":["https://openalex.org/P4310320443","https://openalex.org/P4310320017"],"host_organization_lineage_names":["Mary Ann Liebert, Inc.","SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Viral Immunology","raw_type":"journal-article"},{"id":"pmid:33656935","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/33656935","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Viral immunology","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9907000064849854}],"study_designs":[{"display_name":"Observational Study","id":"https://openalex.org/study-designs/observational-study"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":31,"referenced_works":["https://openalex.org/W1991656907","https://openalex.org/W2001452004","https://openalex.org/W2013103459","https://openalex.org/W2063036448","https://openalex.org/W2063432056","https://openalex.org/W2069075878","https://openalex.org/W2079203175","https://openalex.org/W2145380311","https://openalex.org/W2913280121","https://openalex.org/W3003217347","https://openalex.org/W3012846954","https://openalex.org/W3012925204","https://openalex.org/W3013213522","https://openalex.org/W3013985547","https://openalex.org/W3015546310","https://openalex.org/W3016182787","https://openalex.org/W3016200057","https://openalex.org/W3017962953","https://openalex.org/W3018013720","https://openalex.org/W3021544284","https://openalex.org/W3021590963","https://openalex.org/W3023770076","https://openalex.org/W3025631553","https://openalex.org/W3033022675","https://openalex.org/W3040725637","https://openalex.org/W3041225163","https://openalex.org/W3082474729","https://openalex.org/W3091814234","https://openalex.org/W3093622443","https://openalex.org/W3112389805","https://openalex.org/W3117978409"],"related_works":["https://openalex.org/W4223445767","https://openalex.org/W3109631032","https://openalex.org/W3138988952","https://openalex.org/W4399304249","https://openalex.org/W3045569863","https://openalex.org/W4225972101","https://openalex.org/W3195763591","https://openalex.org/W3082162733","https://openalex.org/W3136117981","https://openalex.org/W3138742881"],"abstract_inverted_index":{"For":[0,55],"the":[1,10,134,144,158],"assessment":[2],"of":[3,12,22,38,48,105,199],"vaccine-induced":[4],"immune":[5],"response":[6],"and":[7,40,52,82,96,170,201],"to":[8,19,34,113],"understand":[9],"role":[11],"antibodies":[13,24,132,172],"in":[14,25,50,109,133,161,166,188,196],"neutralization,":[15],"it":[16],"is":[17],"necessary":[18],"assess":[20],"dynamics":[21],"various":[23],"patients":[26,68,98,127],"with":[27,157,175,183],"different":[28,45,102],"clinical":[29,106],"manifestations.":[30],"This":[31],"study":[32],"aims":[33],"quantitate":[35],"circulating":[36],"levels":[37],"IgA/IgG":[39,131],"IgG":[41,83,184],"subtypes":[42],"induced":[43],"at":[44,101],"days":[46],"postonset":[47,104],"symptoms,":[49],"severe":[51,72,95,148,167],"nonsevere":[53,97],"patients.":[54],"this,":[56],"serum":[57],"or":[58],"plasma":[59],"samples":[60],"(n":[61],"=":[62],"146)":[63],"collected":[64],"from":[65],"79":[66],"COVID-19":[67],"were":[69,90,99,111,128],"used.":[70],"Indirect":[71],"acute":[73],"respiratory":[74],"syndrome":[75],"coronavirus":[76],"2":[77],"(SARS-CoV-2)":[78],"specific":[79,85],"IgA,":[80],"IgG,":[81],"subtype":[84],"enzyme-linked":[86],"immunosorbent":[87],"assays":[88],"(ELISAs)":[89],"performed.":[91],"Antibody":[92],"titers":[93,117,139,152,155,160],"between":[94],"compared":[100,112],"times":[103],"symptoms.":[107],"Titers":[108],"ELISA":[110,138,159],"neutralizing":[114],"antibody":[115],"(Nab)":[116],"determined":[118],"by":[119],"plaque":[120],"reduction":[121],"neutralization":[122],"test":[123],"(PRNT).":[124],"Over":[125],"75%":[126],"positive":[129],"for":[130],"first":[135,145],"week.":[136],"The":[137,177],"did":[140],"not":[141,165],"differ":[142],"during":[143],"week;":[146],"however,":[147],"disease":[149,203],"exhibited":[150],"raised":[151],"thereafter.":[153],"Nab":[154],"correlated":[156,173],"mild":[162],"presentation":[163],"but":[164],"disease.":[168],"IgA":[169,181],"IgG1":[171],"stronger":[174],"Nabs.":[176],"findings":[178],"highlighted":[179],"that":[180],"together":[182],"play":[185],"an":[186],"important":[187],"SARS-CoV-2":[189],"neutralization.":[190],"These":[191],"results":[192],"will":[193],"prove":[194],"useful":[195],"assessing":[197],"efficacy":[198],"vaccines":[200],"understanding":[202],"pathogenesis.":[204]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":7},{"year":2023,"cited_by_count":5},{"year":2022,"cited_by_count":11},{"year":2021,"cited_by_count":10}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2021-03-15T00:00:00"}
